These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15911328)

  • 1. PARP-1 inhibition to treat cancer, ischemia, inflammation.
    Graziani G; Battaini F; Zhang J
    Pharmacol Res; 2005 Jul; 52(1):1-4. PubMed ID: 15911328
    [No Abstract]   [Full Text] [Related]  

  • 2. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A
    Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PARP (poly(ADP-ribose) polymerase) family].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():71-7. PubMed ID: 23513815
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3. Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia.
    Pellicciari R; Camaioni E; Costantino G
    Prog Med Chem; 2004; 42():125-69. PubMed ID: 15003720
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.
    Kauppinen TM
    Neurochem Int; 2007 Jun; 50(7-8):954-8. PubMed ID: 17222947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP inhibitors and heart failure--translational medicine caught in the act.
    Booz GW
    Congest Heart Fail; 2007; 13(2):105-12. PubMed ID: 17392615
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the activity of poly (ADP-ribose) polymerase in ischemia-reperfusion injury.
    Thiemermann C
    Shock; 2000 Aug; 14(2):142-3. PubMed ID: 10947157
    [No Abstract]   [Full Text] [Related]  

  • 9. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.
    Moroni F
    Curr Opin Pharmacol; 2008 Feb; 8(1):96-103. PubMed ID: 18032109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribosyl)ation in asthma and other lung diseases.
    Virág L
    Pharmacol Res; 2005 Jul; 52(1):83-92. PubMed ID: 15911336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
    McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
    Cavone L; Chiarugi A
    Trends Mol Med; 2012 Feb; 18(2):92-100. PubMed ID: 22078487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP inhibitors for cancer therapy.
    Curtin NJ
    Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Poly(ADP-ribosa)polymerase--the relationships with life span and carcinogenesis].
    Piskunova TS; Iurova MN; Zabezhinskiĭ MA; Anisimov VN
    Adv Gerontol; 2007; 20(2):82-90. PubMed ID: 18306694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibitors: polypharmacology versus selective inhibition.
    Ekblad T; Camaioni E; Schüler H; Macchiarulo A
    FEBS J; 2013 Aug; 280(15):3563-75. PubMed ID: 23601167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
    Mota RA; Hernández-Espinosa D; Galbis-Martinez L; Ordoñez A; Miñano A; Parrilla P; Vicente V; Corral J; Yélamos J
    Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
    Alano CC; Kauppinen TM; Valls AV; Swanson RA
    Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.